Literature DB >> 23580681

Challenging diagnosis of a jejunal adenocarcinoma with ovarian metastasis: report of an unusual case.

Yang Yang Huang1, Jeremy John Pratt, Marcus Dabner, William Tjhin.   

Abstract

We report the first documented case of ovarian metastasis from a jejunal primary adenocarcinoma in an Australian patient. The presentation was unusual, initially a suspicious abdominal nodule in the epigastric area, which turned out to be an adenocarcinoma of possible intestinal origin. Gastroscopy and colonoscopy were performed with no suspicious lesion identified. Abdominal and pelvic ultrasound imaging showed a complex pelvic mass suspicious of ovarian cancer. Laparoscopy was performed to exclude possibility of ovarian cancer and small bowel cancer. The ovarian mass showed similar features from the epigastric nodule, again suggestive of intestinal primary. Definitive diagnosis was obtained when the patient represented 2 months later with malignant bowel obstruction requiring palliative resection of the proximal jejunum. This case demonstrates the difficulty in diagnosing ovarian metastasis from a small bowel primary, which has the potential to mimic an ovarian primary tumour clinically, and a large bowel or ovarian primary pathologically.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23580681      PMCID: PMC3645799          DOI: 10.1136/bcr-2013-008842

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  39 in total

Review 1.  Application of immunohistochemistry to gynecologic pathology.

Authors:  Khush Mittal; Robert Soslow; W G McCluggage
Journal:  Arch Pathol Lab Med       Date:  2008-03       Impact factor: 5.534

2.  Huge ovarian metastasis from jejunal cancer occurring immediately after initial operation.

Authors:  Chouhei Sakakura; Akeo Hagiwara; Tetsuji Yoshikawa; Takuo Hamada; Hisakazu Yamagishi
Journal:  Hepatogastroenterology       Date:  2005 Mar-Apr

3.  Immunohistochemical differentiation of metastatic breast carcinomas from metastatic adenocarcinomas of other common primary sites.

Authors:  O Kaufmann; T Deidesheimer; M Muehlenberg; P Deicke; M Dietel
Journal:  Histopathology       Date:  1996-09       Impact factor: 5.087

4.  Cytokeratin 7 and 20 expression in cholangiocarcinomas varies along the biliary tract but still differs from that in colorectal carcinoma metastasis.

Authors:  A Rullier; B Le Bail; R Fawaz; J F Blanc; J Saric; P Bioulac-Sage
Journal:  Am J Surg Pathol       Date:  2000-06       Impact factor: 6.394

5.  Adenocarcinomas of the jejunum and ileum: a 25-year experience.

Authors:  Mustafa M Ugurlu; Oktar Asoglu; Dean D Potter; Sunni A Barnes; William S Harmsen; John H Donohue
Journal:  J Gastrointest Surg       Date:  2005-11       Impact factor: 3.452

6.  TTF-1 expression in pulmonary adenocarcinomas.

Authors:  Yasushi Yatabe; Tetsuya Mitsudomi; Takashi Takahashi
Journal:  Am J Surg Pathol       Date:  2002-06       Impact factor: 6.394

7.  Adenocarcinoma of the small intestine.

Authors:  K Ouriel; J T Adams
Journal:  Am J Surg       Date:  1984-01       Impact factor: 2.565

8.  Expression of mucins and cytokeratins in primary carcinomas of the digestive system.

Authors:  Min Jong Lee; Hye Seung Lee; Woo Ho Kim; Yunhee Choi; Mihi Yang
Journal:  Mod Pathol       Date:  2003-05       Impact factor: 7.842

9.  Utility of cytokeratin immunostaining in separating pulmonary adenocarcinomas from colonic adenocarcinomas.

Authors:  T S Loy; R D Calaluce
Journal:  Am J Clin Pathol       Date:  1994-12       Impact factor: 2.493

10.  Immunophenotype and molecular characterisation of adenocarcinoma of the small intestine.

Authors:  M J Overman; J Pozadzides; S Kopetz; S Wen; J L Abbruzzese; R A Wolff; H Wang
Journal:  Br J Cancer       Date:  2009-11-24       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.